Marcus Daniel Lancé

Marcus Daniel Lancé

Auto-generated profile, based on publicly available information

Marcus Daniel Lancé

Department of Anesthesiology, Intensive Care Unit and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2020 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
KBKatarzyna Brzeźniakiewicz-Janus
Katarzyna Brzeźniakiewicz-Janus
JRJoanna Rupa-Matysek
Joanna Rupa-Matysek
Andrzej TukiendorfAndrzej Tukiendorf
Andrzej Tukiendorf
TJTomasz Janus
Tomasz Janus
MFMirosław Franków
Mirosław Franków
LGLidia Gil
Lidia Gil
This study presents the statistical results of patients who had been recently discharged from hospital within one month after their treatment in the emergency department (ED). Using routine (14,881) MCV and RDW measurements and statistical tools, we could predict acute mortality in these patients (N = 1158), adjusted for age. It is likely that an increase in the MCV and RDW parameters may correlate in some of our older patients with a poor prognosis with an increased level of circulating IGF–I, which affects red blood cell parameters. The research presents the prognostic statistics of the analyzed clinical factors as well as speculates on the potential correlation of these parameters with the regenerative potential of stem-cell compartment. Analysis shows that both MCV and RDW are statistically significant (Area Under Curve [AUC], lower CI 95% >50%) predictors of acute mortality in ED patients. The classification of patients based on their MCV threshold (= 92.2 units) indicates a proper clinical prognosis in nearly 6 of 10 subjects (AUC >58%), whereas taking into account RDW (=13.8%) indicates a proper clinical prognosis in no more than 7 of 10 individuals. The report concludes that by employing strongly fitting (95%) quadratic modeling of the ORs against the biomarkers studied, one can notice a similar relationship between MCV and RDW as diagnostic tools to predict regenerative potential and clinical outcomes in older patients. Although RDW alone had a 10% higher diagnostic value in terms of predicting early death in the emergency department in patients that were admitted to the ED and subsequently hospitalized, also taking the MCV measurement improved accuracy in predicting clinical outcomes by 2.5% compared to RDW alone.

16 July 2020 in Disease Markers
Verified
Journal Article
Open access
PDF file
KBKatarzyna Brzeźniakiewicz-Janus
Katarzyna Brzeźniakiewicz-Janus
MLMarcus Daniel Lancé
Marcus Daniel Lancé
Andrzej TukiendorfAndrzej Tukiendorf
Andrzej Tukiendorf
TJTomasz Janus
Tomasz Janus
MFMirosław Franków
Mirosław Franków
LGLidia Gil
Lidia Gil
Background.Complete blood count (CBC), red cell distribution width (RDW), mean platelet volume (MPV), mean corpuscular volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), or platelet (PLT) count are referred as predictors of adverse clinical outcomes in patients. The aim of the research was to identify potential factors of acute mortality in Polish emergency department (ED) patients by using selected hematological biomarkers and routine statistical tools. Methods. The study presents statistical results on patients who were recently discharged from inpatient facilities within one month prior to the index ED visit. In total, the analysis comprised 14,881 patients with the first RDW, MPV, MCV, MCH, MCHC, or PLT biomarkers' measurements recorded in the emergency department within the years 2016-2019 with a subsequent one month of all-cause mortality observation. The patients were classified with the codes of the International Statistical Classification of Diseases and Related Health Problems after 10(th) Revision (ICD10). Results. Based on the analysis of RDW, MPV, MCV, MCH, MCHC, and PLT on acute deaths in patients, we establish strong linear and quadratic relationships between the risk factors under study and the clinical response (P95 fL), whereas MCH, MCHC, and PLT have no impact on the excess acute mortality in ED patients.